VC funding makes sense when you need millions across multiple rounds for things like manufacturing lines or clinical trials. SBIR grants max out at a few hundred thousand, which won't cut it for capital-intensive projects. If your startup isn't research-driven, VC is often your only real option.
VCs can be great if you need big capital. For example, manufacturing line, clinical trials, or a big marketing push. SBIRs cap out at the hundreds of thousands of dollars in a Phase 1 application, whereas VCs can write multi-million dollar checks and keep funding you through multiple rounds. Sometimes for capital-intensive ventures, VC is the only choice. Also, if your startup is not research-driven, maybe VC is the best route for
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
